向公平的Mpox疫苗接种覆盖率取得的进展:短缺分析 - 美国,2022年5月至2023年4月
MMWR. Morbidity and mortality weekly report
|June 8, 2023
概括
麻疹疫苗接种工作在各个种族群体的覆盖率有所增加,但仍然存在重大缺陷,特别是在黑人和AI/AN人群中. 实现公平需要有针对性的战略来解决JYNNEOS疫苗接种中这些持续存在的差异.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗股权公司的疫苗股权
背景情况:
- 2022年跨国mpox (麻疹) 疫情不成比例地影响了与男性发生性关系的男性 (MSM),并突出了发生率的种族和民族差异.
- 国家mopox疫苗接种战略优先考虑对暴露风险较高的人群给予JYNNEOS疫苗.
研究的目的:
- 分析美国不同种族和种族群体中mopox疫苗接种覆盖率的公平性.
- 评估2022年5月至2023年4月的mopox疫苗接种缺口及其减少趋势.
主要方法:
- 进行了缺口分析,将缺口定义为尚未接种疫苗的疫苗适用人口的百分比.
- 按种族和种族分层计算的每月mopox疫苗接种不足.
- 与上个月相比,在缺口中确定了每月的百分比减少.
主要成果:
- 在所有种族和族裔群体中,mopox疫苗接种总体缺口减少,但到2023年4月,66.0%的符合条件的人仍未接种疫苗.
- 在非西班牙裔黑人 (77.9%) 和非西班牙裔美国印第安人或阿拉斯加土著人 (74.5%) 之间观察到最大的疫苗接种不足.
- 虽然在8月和9月出现了大幅减少的缺口,但黑人个人的进展较慢,这表明持续的股权挑战.
结论:
- 尽管疫苗接种覆盖率增加,但仍然存在巨大的差异,黑人和AI/AN人口经历了最大的mopox疫苗接种短缺.
- 实现公平的JYNNEOS疫苗接种覆盖率需要有针对性的干预措施,以显著减少黑人和AI/AN社区之间的缺口.
- 在对传染病爆发的公共卫生反应中,持续关注公平至关重要.
相关概念视频
01:51Vaccinations
44.8K
Overview
44.8K
01:30Preventive Healthcare Services
1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
01:08Prevalence and Incidence
644
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
644
01:29Bias in Epidemiological Studies
384
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
384
01:12Analysis of Population Pharmacokinetic Data
307
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
307
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
105
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
105